Francisco D. Salva
CIK 1834051 · President and CEO · last filed 2026-04-22
Francisco D. Salva is a President and CEO who has filed 10 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for AZTR, was dated Apr 22, 2026. Across all open-market trades the lifetime net is +$100.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $71.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$71.6K
3
10
$100.0K
Holdings By Company
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-22 | AZTR | Grant (A) | — | $0 | EDGAR |
| 2026-03-20 | AZTR | Buy (P) | — | $0 | EDGAR |
| 2025-12-22 | AZTR | Grant (A) | — | $0 | EDGAR |
| 2024-05-28 | VINC | Grant (A) | — | $0 | EDGAR |
| 2024-02-15 | AZTR | Buy (P) | +333,300 | $100.0K | EDGAR |
| 2023-06-23 | AZTR | Grant (A) | +5,000 | $25.0K | EDGAR |
| 2023-05-30 | VINC | Grant (A) | — | $0 | EDGAR |
| 2022-05-31 | VINC | Grant (A) | — | $0 | EDGAR |
| 2021-05-14 | VINC | Grant (A) | — | $0 | EDGAR |
| 2020-12-28 | Vincerx Pharma, Inc. (VINCW) Delisted | Grant (A) | — | $0 | EDGAR |